Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats (Q48296142)

10 February 2018

title

Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats (English)

1 reference

10 February 2018

0 references

3

1 reference

10 February 2018

author name string

Mlynarik M

1

1 reference

10 February 2018

Zelena D

2

1 reference

10 February 2018

Makara GB

4

1 reference

10 February 2018

Jezova D

5

1 reference

10 February 2018

publication date

30 December 2006

1 reference

10 February 2018

published in

Hormones and Behaviour

1 reference

10 February 2018

volume

51

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

395-405

1 reference

10 February 2018

Neuromodulation of memory in the hippocampus by vasopressin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

The role of corticotropin-releasing factor in depression and anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Oxytocin acts as an antidepressant in two animal models of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Gender-specific effect of maternal deprivation on anxiety and corticotropin-releasing hormone mRNA expression in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Neuroendocrine pharmacology of stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

CRH, stress, and major depression: a psychobiological interplay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Assessing antidepressant activity in rodents: recent developments and future needs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Anatomy and function of extrahypothalamic vasopressin systems in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Further neuroendocrine evidence of enhanced vasopressin V3 receptor responses in melancholic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosine hydroxylase mRNA levels decrease in both sexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Vasopressin released within the septal brain area during swim stress modulates the behavioural stress response in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Swim stress triggers the release of vasopressin within the suprachiasmatic nucleus of male rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Processing of frameshifted vasopressin precursors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Behavioral characteristics of Roman high avoidance rats homozygous for diabetes insipidus (RHA: di/di).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Rodent models of depression: reexamining validity without anthropomorphic inference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Enhanced motivation to self-administer cocaine is predicted by self-grooming behaviour and relates to dopamine release in the rat medial prefrontal cortex and amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Individual differences in the effects of serotonergic anxiolytic drugs on the motivation to self-administer cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

The combined dexamethasone/CRH test as a potential surrogate marker in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Effects of ventrolateral-ventromedial thalamic lesions on motor coordination and spatial orientation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Neurobiological basis of depression: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Coping styles in animals: current status in behavior and stress-physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Corticosteroids in relation to fear, anxiety and psychopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Born to be anxious: neuroendocrine and genetic correlates of trait anxiety in HAB rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

The role of vasopressin in hypothalamo-pituitary-adrenal axis activation during stress: an assessment of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Olfactory bulbectomy increases vasopressin, but not corticotropin-releasing hormone, content in the external layer of the median eminence of male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

The role of corticotropin releasing factor in depressive illness: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

The effects of anxiolytics and other agents on rat grooming behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Vasopressin, immobilization, and the dexamethasone suppression test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Forced swimming test in mice: a review of antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Facilitation of affiliation and pair-bond formation by vasopressin receptor gene transfer into the ventral forebrain of a monogamous vole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Depression: a new animal model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Behavioural despair in rats: A new model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Vasopressin as a target for antidepressant development: an assessment of the available evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Psychoneuroendocrinological links between chronic stress and depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Effect of environmental stressors on time course, variability and form of self-grooming in the rat: handling, social contact, defeat, novelty, restraint and fur moistening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Plasma levels of arginine vasopressin elevated in patients with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Vasopressin V1b receptor knockout reduces aggressive behavior in male mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Chronic mild stress-induced anhedonia: a realistic animal model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Simultaneous blockade of two glutamate receptor subtypes (NMDA and AMPA) results in stressor-specific inhibition of prolactin and corticotropin release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Maternal genotype influences stress reactivity of vasopressin-deficient brattleboro rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.12.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YHBEH.2006.12.007

1 reference

10 February 2018

1 reference

10 February 2018